Webseiten-Bericht für ms-research.be

ms-research.be

Webseiten-Bericht für ms-research.be

 Generiert am 02 April 2026 14:59 PM

Aktuelle Statistiken? UPDATE !

Der Wert ist 71/100

SEO Inhalte

Seitentitel

Knowledge Centre for Multiple Sclerosis — Fondation Charcot Stichting

Länge : 69

Perfekt, denn Ihr Seitentitel enthält zwischen 10 und 70 Anzahl Zeichen.

Seitenbeschreibung

The Charcot Foundation supports multiple sclerosis research in Belgium since 1987. Symptoms, treatments and scientific advances.

Länge : 128

Großartig, denn Ihre Seitenbeschreibung enthält zwischen 70 und 160 Anzahl Zeichen.

Suchbegriffe

Nicht so gut. Wir konnten keine META-Suchbegriffe auf Ihrer Webseite finden. Benutzen Sie dieses kostenlose Werkzeug um META-Suchbegriffe zu erzeugen.

Og META Eigenschaften

Sehr gut, denn diese Webseite nutzt die Vorteile aus den Og Properties.

Eigenschaft Inhalt
title Knowledge Centre for Multiple Sclerosis — Fondation Charcot Stichting
description The Charcot Foundation supports multiple sclerosis research in Belgium since 1987. Symptoms, treatments and scientific advances.
image https://cdn.prod.website-files.com/682f0f64cb6a432620017802/683b362f278e9155a2003ae3_Opengraph.jpg
type website

Überschriften

H1 H2 H3 H4 H5 H6
1 11 47 0 0 0
  • [H1] 3 missions to fight multiple sclerosis‍
  • [H2] Multiple sclerosis, Decrypted
  • [H2] News
  • [H2] Last newsletters
  • [H2] Scientific publications
  • [H2] 113 projects supported
  • [H2] Key dates of Research
  • [H2] Our action
  • [H2] Support research
  • [H2] Frequently asked questions
  • [H2] Stay informed
  • [H2] Footer
  • [H3] From generosity to knowledge: Charcot Funds 2025 publications updated
  • [H3] When a celebration becomes a symbol of research
  • [H3] A December of solidarity: chocolate, coffee, and research against multiple sclerosis
  • [H3] ES 2026 Newsletter
  • [H3] Newsletter 58
  • [H3] Newsletter 57
  • [H3] Beyond the innate immune system : rethinking inflammasomes in Multiple Sclerosis
  • [H3] Recent advances in interventions targeting remyelination and a systematic review of remyelinating effects of approved disease-modifying treatments for Multiple Sclerosis
  • [H3] Task-induced 1/f slope modulation as a paradigm-independent marker of cognitive control in multiple sclerosis
  • [H3] FCRL5, a B-Cell marker with novel diagnostic and Prognostic value for Multiple Sclerosis
  • [H3] UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation
  • [H3] Critical evaluation of saponin as a permeabilizer for anandamide encapsulation in extracellular vesicles
  • [H3] AAV-based intracerebral administrationof BDNF promotes myelin repair and cognitive improvement after cuprizone-induced remyelination
  • [H3] Lipid nanoparticle-mediated delivery of microRNA-124 reduces neuroinflammation
  • [H3] Regulatory T cell – blood brain barrier interactions drive loss of remyelination capacity
  • [H3] Targeting proteolytic pathways in MS: modulating macrophage responses to myelin debris
  • [H3] Unveiling the Role of FCRL5⁺ B Cells in the Immunopathogenesis of Multiple Sclerosis
  • [H3] Defining the epigenetic fingerprint of EBV in MS through single-cell multiomic approach
  • [H3] MSMacGut: Genetic Stratification of Gut-Brain Axis Dysfunction in Multiple Sclerosis
  • [H3] Targeted Nanomedicines for cGAS-STING Silencing in Multiple Sclerosis
  • [H3] 1868
  • [H3] 1942
  • [H3] 1981
  • [H3] 1993
  • [H3] 2010
  • [H3] 2023
  • [H3] Charcot 2025 Fund
  • [H3] Belgium, a precursor country
  • [H3] Research support
  • [H3] Make a Gift
  • [H3] Leave a Legacy
  • [H3] Standing order
  • [H3] Events
  • [H3] What is multiple sclerosis?
  • [H3] What is the situation in Belgium?
  • [H3] What is the Belgian Charcot Foundation?
  • [H3] What is the role of the Belgian Charcot Foundation?
  • [H3] How does the Belgian Charcot Foundation function?
  • [H3] Where do the funds come from?
  • [H3] Who receives grants from the Foundation?
  • [H3] What is the current status of research on multiple sclerosis?
  • [H3] What prospects for the future?
  • [H3] What hope for the future?
  • [H3] Fast access
  • [H3] MS
  • [H3] Research
  • [H3] The Foundation

Bilder

Es konnten 38 Bilder auf dieser Webseite gefunden werden.

Gut, denn die meisten Ihrer Bilder verwenden das ALT-Attribut.

Text/HTML Verhältnis

Anteil : 6%

Das Text zu HTML Code Verhältnis dieser Webseite ist niedriger als 15 Prozent, was bedeutet, dass Sie mehr Inhalte für Ihre Webseite schreiben sollten.

Flash

Perfekt, denn es wurde kein Flash auf Ihrer Webseite gefunden.

IFrame

Großartig, denn Sie verwenden keine IFrames auf Ihrer Webseite.

URL Rewrite

Gut. Ihre Links sind für Suchmaschinen gut lesbar (sprechende Links)!

Underscores in the URLs

Perfekt! Wir haben keine Unterstriche in Ihren Links entdeckt.

In-page links

We found a total of 165 links including 0 link(s) to files

Anker Typ Natürlich
Skip to main content intern natürliche Links
- intern natürliche Links
Defining multiple sclerosis intern natürliche Links
The different forms of MS intern natürliche Links
Symptoms of MS intern natürliche Links
MS-CMT-ALS comparison intern natürliche Links
Glossary intern natürliche Links
History of multiple sclerosis intern natürliche Links
Diagnosis of MS intern natürliche Links
Epidemiology intern natürliche Links
Genetic factors intern natürliche Links
Environmental Factors intern natürliche Links
Co-morbidities intern natürliche Links
Treatments for remitting forms intern natürliche Links
Side effects of treatments intern natürliche Links
Treatments for progressive forms intern natürliche Links
Managing the announcement of the diagnosis intern natürliche Links
Neuroprotection and remyelination intern natürliche Links
Cell therapy intern natürliche Links
The future of MS research intern natürliche Links
Scientific publications intern natürliche Links
Call for projects intern natürliche Links
Charcot Fund intern natürliche Links
Charcot Clinical Fellowship intern natürliche Links
Charcot PhD Fellowship intern natürliche Links
Clinical research intern natürliche Links
Scientific newsletters intern natürliche Links
Objectives intern natürliche Links
Composition intern natürliche Links
History intern natürliche Links
Press intern natürliche Links
Useful links intern natürliche Links
Make a gift intern natürliche Links
Leave a legacy intern natürliche Links
Standing order intern natürliche Links
Events extern natürliche Links
News intern natürliche Links
Contact intern natürliche Links
fr intern natürliche Links
nl intern natürliche Links
en intern natürliche Links
- intern natürliche Links
Defining multiple sclerosis intern natürliche Links
The different forms of MS intern natürliche Links
Symptoms of MS intern natürliche Links
MS-CMT-ALS comparison intern natürliche Links
Glossary intern natürliche Links
History of multiple sclerosis intern natürliche Links
Diagnosis of MS intern natürliche Links
Epidemiology intern natürliche Links
Genetic factors intern natürliche Links
Environmental Factors intern natürliche Links
Co-morbidities intern natürliche Links
Treatments for remitting forms intern natürliche Links
Side effects of treatments intern natürliche Links
Treatments for progressive forms intern natürliche Links
Managing the announcement of the diagnosis intern natürliche Links
Neuroprotection and remyelination intern natürliche Links
Cell therapy intern natürliche Links
The future of MS research intern natürliche Links
Scientific publications intern natürliche Links
Call for projects intern natürliche Links
Charcot Fund intern natürliche Links
Charcot Clinical Fellowship intern natürliche Links
Charcot PhD Fellowship intern natürliche Links
Clinical research intern natürliche Links
Scientific newsletters intern natürliche Links
Objectives intern natürliche Links
Composition intern natürliche Links
History intern natürliche Links
Press intern natürliche Links
Useful links intern natürliche Links
Make a gift intern natürliche Links
Leave a legacy intern natürliche Links
Standing order intern natürliche Links
Events extern natürliche Links
News intern natürliche Links
Contact intern natürliche Links
fr intern natürliche Links
nl intern natürliche Links
en intern natürliche Links
Make a gift extern natürliche Links
Leave a Legacy intern natürliche Links
🏃🏼‍♀️20km Brussels extern natürliche Links
Support extern natürliche Links
Finance intern natürliche Links
Stimulate intern natürliche Links
Inform intern natürliche Links
- intern natürliche Links
Defining multiple sclerosis intern natürliche Links
The different forms of MS intern natürliche Links
Symptoms of MS intern natürliche Links
Diagnosis of MS and differential diagnosis intern natürliche Links
Epidemiology: a predominantly female disease intern natürliche Links
Genetic factors of susceptibility and severity intern natürliche Links
Environmental susceptibility factors intern natürliche Links
Co-morbidities in MS intern natürliche Links
Immunomodulatory treatments for relapsing-remitting MS intern natürliche Links
Side effects of immunomodulatory treatments intern natürliche Links
Current and future immunomodulatory treatments for progressive forms of MS intern natürliche Links
Managing the announcement of the diagnosis intern natürliche Links
Neuroprotection and remyelination: hopes and realities intern natürliche Links
Can cell therapy be applied to MS? intern natürliche Links
The future of MS research intern natürliche Links
Comparison between SEP, CMT and SLA intern natürliche Links
Glossary intern natürliche Links
From generosity to knowledge: Charcot Funds 2025 publications updated intern natürliche Links
When a celebration becomes a symbol of research intern natürliche Links
A December of solidarity: chocolate, coffee, and research against multiple sclerosis intern natürliche Links
All the news intern natürliche Links
February 2026 Special edition ES 2026 Newsletter Multiple Sclerosis : Specific research priorities for 2026 intern natürliche Links
October 2025 Special edition Newsletter 58 From Charcot's history to today's research Charcot: One Name, Three Realities… and 200 Years of Legacy MS Treatments over the Past 30 Years intern natürliche Links
April 2025 Special edition Newsletter 57 Together, we are opening up new prospects Finally, a step forward in the treatment of the secondary progressive forms of multiple sclerosis! The enigma of these double-edged immune cells intern natürliche Links
All newsletters intern natürliche Links
Beyond the innate immune system : rethinking inflammasomes in Multiple Sclerosis intern natürliche Links
Recent advances in interventions targeting remyelination and a systematic review of remyelinating effects of approved disease-modifying treatments for Multiple Sclerosis intern natürliche Links
Task-induced 1/f slope modulation as a paradigm-independent marker of cognitive control in multiple sclerosis intern natürliche Links
FCRL5, a B-Cell marker with novel diagnostic and Prognostic value for Multiple Sclerosis intern natürliche Links
UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation intern natürliche Links
Critical evaluation of saponin as a permeabilizer for anandamide encapsulation in extracellular vesicles intern natürliche Links
AAV-based intracerebral administrationof BDNF promotes myelin repair and cognitive improvement after cuprizone-induced remyelination intern natürliche Links
Lipid nanoparticle-mediated delivery of microRNA-124 reduces neuroinflammation intern natürliche Links
All publications intern natürliche Links
Regulatory T cell – blood brain barrier interactions drive loss of remyelination capacity intern natürliche Links
Targeting proteolytic pathways in MS: modulating macrophage responses to myelin debris intern natürliche Links
Unveiling the Role of FCRL5⁺ B Cells in the Immunopathogenesis of Multiple Sclerosis intern natürliche Links
Defining the epigenetic fingerprint of EBV in MS through single-cell multiomic approach intern natürliche Links
MSMacGut: Genetic Stratification of Gut-Brain Axis Dysfunction in Multiple Sclerosis intern natürliche Links
Targeted Nanomedicines for cGAS-STING Silencing in Multiple Sclerosis intern natürliche Links
Discover the latest projects intern natürliche Links
All dates intern natürliche Links
Skip intern natürliche Links
Discover the projects intern natürliche Links
Make a Gift Support research with a donation of the amount of your choice. Easy to do online and deductible from €40 in Belgium. intern natürliche Links
Leave a Legacy You can bequeath part of your assets to the Charcot Foundation via your will, in favor of research on multiple sclerosis. intern natürliche Links
Standing order Help with a monthly transfer (e.g. €7/month = 1 day of research). Easy to set up via our form or your bank. intern natürliche Links
Events Wedding, birthday, race... Organize or support a solidarity event via our dedicated platform. intern natürliche Links
Privacy policy intern natürliche Links
- intern natürliche Links
- extern natürliche Links
- extern natürliche Links
- extern natürliche Links
- extern natürliche Links
+32 (0) 2 426 49 30 extern natürliche Links
News intern natürliche Links
Support intern natürliche Links
Contact intern natürliche Links
Confidentiality intern natürliche Links
Everything about MS intern natürliche Links
Comparison intern natürliche Links
Glossary intern natürliche Links
Scientific publications intern natürliche Links
Charcot Fund intern natürliche Links
Clinical Fellowship intern natürliche Links
PhD Fellowship intern natürliche Links
Clinical research intern natürliche Links
Scientific newsletters intern natürliche Links
Objectives intern natürliche Links
Composition intern natürliche Links
History intern natürliche Links
Press intern natürliche Links
Useful links intern natürliche Links
Contact intern natürliche Links
- extern natürliche Links
- extern natürliche Links

SEO Suchbegriffe

Suchbegriffswolke

charcot multiple belgian all sclerosis treatments foundation research disease projects

Keywords Consistency

Suchbegriff Inhalt Seitentitel Suchbegriffe Seitenbeschreibung Überschriften
research 46
multiple 37
sclerosis 36
charcot 30
foundation 27

Benutzerfreundlichkeit

URL

Domain : ms-research.be

Länge : 14

Favoriten Icon

Gut. Die Webseite hat ein Favicon.

Druckeigenschaften

Es konnten keine druckfreundlichen CSS-Angaben gefunden werden.

Sprache

Gut, denn Sie haben in den META-Elementen eine Sprache deklariert: en.

Dublin Core

Diese Webseite nutzt nicht die Vorteile der Dublin Core Elemente.

Dokument

Doctype

HTML 5

Verschlüsselung

Perfekt, denn Ihre Webseite deklariert einen Zeichensatz: UTF-8.

W3C Validität

Fehler : 0

Warnungen : 0

E-Mail Datenschutz

Sehr gut, denn es wurde keine E-Mail Adresse im Klartext auf Ihrer Webseite gefunden.

Veraltetes HTML

Sehr gut! Sie verwenden aktuelle HTML Tags in Ihrem Webseitenquelltext.

Tipps zur Webseitengeschwindigkeit

Sehr gut, denn Ihre Webseite benutzt keine verschachtelten Tabellen.
Schlecht, denn es wurden CSS-Angaben in HTML-Elementen entdeckt. Diese Angaben sollten in ein entsprechendes CSS-Stylesheet verlagert werden.
Gut, denn Ihre Webseite enthält nur wenig CSS-Dateien.
Perfekt, denn Ihre Webseite enthät nur wenig Javascript-Dateien.
Gut! Sie nutzen die Vorteile von gzip.

Mobile

Mobile Optimierung

Apple Icon
META Viewport Tag
Flash Inhalt

Optimierung

XML-Sitemap

Perfekt! Ihre Seite hat eine XML-Sitemap.

https://www.fondation-charcot.org/en

Robots.txt

http://ms-research.be/robots.txt

Sehr gut! Ihre Webseite enthält eine robots.txt-Datei.

Analytics

Sehr gut, Ihre Website hat ein Analyse-Tool.

   Google Analytics

PageSpeed Insights

Gerät
Kategorien

Website-Überprüfung

Website-Überprüfung ist ein kostenloses SEO Werkzeug zur Analyse Ihrer Webseite